Church & Dwight vs Stepan
CHD and SCL side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CHD and SCL compare
Church & Dwight is the larger company, worth 18 times as much as Stepan ($26.4B against $1.5B).
On earnings, Church & Dwight is cheaper: it trades at 34.5× trailing earnings, against 347× for Stepan.
Stepan grew revenue faster over the last twelve months (10.0% versus 1.7% for Church & Dwight).
Church & Dwight keeps more of each dollar of sales as profit, with a net margin of 12.4% compared with 0.17% at Stepan.
Both pay dividends: Church & Dwight yields 1.1% and Stepan 2.4%.
Church & Dwight scores higher on the StockData Score (16 against 7 for Stepan), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHD | SCL |
|---|---|---|
| Size and price | ||
| Market cap | $26.4B | $1.5B |
| Share price | $112.02 | $65.94 |
| Change, 1 year | 32.3% | 50.0% |
| Change, 5 years | 21.5% | −45.5% |
| Beta (5Y) | 0.30 | 0.87 |
| Employees | 5,550 | – |
| StockData Score | ||
| Total score | 16 (better) | 7 |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 1 |
| Health score | 4 (better) | 1 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 34.5× (better) | 347× |
| P/S | 4.2× | 0.6× (better) |
| P/B | 5.9× | 1.2× (better) |
| EV/EBITDA | 25.1× | 13.4× (better) |
| P/FCF | 25.0× (better) | 329× |
| PEG | 1.60 | – |
| FCF yield | 4.0% (better) | 0.30% |
| Fair value | $92.11 | $56.29 |
| Margin of safety | −21.6% | −17.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.7% | 10.0% (better) |
| Revenue growth, 5Y average | 4.8% (better) | 4.5% |
| Net income growth (TTM) | −0.98% (better) | −90.4% |
| EPS growth (TTM) | 2.2% (better) | −90.4% |
| EPS growth, 5Y average | −0.65% (better) | −17.8% |
| Profitability | ||
| Gross margin | 46.1% (better) | 12.0% |
| Operating margin | 18.0% (better) | 0.95% |
| Net margin | 12.4% (better) | 0.17% |
| FCF margin | 16.9% (better) | 0.18% |
| Return on equity | 17.8% (better) | 0.35% |
| Return on invested capital | 14.3% (better) | 1.4% |
| Financial health | ||
| Debt / equity | 0.49 (better) | 0.52 |
| Net debt / EBITDA | 1.56 (better) | 3.53 |
| Interest coverage | 11.6× | – |
| Current ratio | 0.96 | 1.32 (better) |
| Altman Z-score | 5.40 (better) | 2.72 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | 2.4% (better) |
| Payout ratio | 37.5% | 830% |
| Years of dividend growth | 16 | 16 |
| Dividend growth, 5Y average | 4.2% | 6.5% (better) |
| Shareholder yield | 1.1% | 2.4% (better) |
| Ownership | ||
| Held by institutions | 92.7% | 87.6% |
| Held by insiders | 0.14% | 4.8% |
| Insider net buying, 12 months | −$23.3M | – |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.5% | 3.1% |
Go deeper
- CHD stock overview
- CHD income statement
- CHD valuation and score
- SCL stock overview
- SCL income statement
- SCL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.